Deutsch English Français

Contact

EP1140139

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1140139

EP1140139 - USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA [Right-click to bookmark this link]
Former [2001/41]	METHOD FOR THE TREATMENT OF CEREBRAL ISCHAEMIA AND USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA
	[2001/46]
Status	Patent maintained as amended Status updated on 13.02.2009 Database last updated on 03.04.2025
Most recent event Tooltip	13.02.2009	Patent maintained (B2 publication)	published on 18.03.2009 [2009/12]
Applicant(s)	For all designated states Ehrenreich, Hannelore Valentinsbreite 21 37077 Göttingen / DE
	For all designated states Gleiter, Christoph Am Unteren Herrlesberg 5 72074 Tübingen / DE
	[2009/12]
Former [2001/41]	For all designated states Ehrenreich, Hannelore Valentinsbreite 21 37077 Göttingen / DE
	For all designated states Gleiter, Christophe Am Unteren Herrlesberg 5 72074 Tübingen / DE
Inventor(s)	01 / see applicant ...
	[2001/41]
Representative(s)	Pfenning, Meinig & Partner mbB Patent- und Rechtsanwälte Theresienhöhe 11a 80339 München / DE
	[N/P]
Former [2001/41]	Pfenning, Meinig & Partner Mozartstrasse 17 80336 München / DE
Application number, filing date	99966958.3	13.12.1999
	[2001/41]
	WO1999EP09864
Priority number, date	DE19981057609	14.12.1998 Original published format: DE 19857609
	[2001/41]
Filing language	DE
Procedural language	DE
Publication	Type:	A2 Application without search report
	No.:	WO0035475
	Date:	22.06.2000
	Language:	DE
	[2000/25]
	Type:	A2 Application without search report
	No.:	EP1140139
	Date:	10.10.2001
	Language:	DE
	The application published by WIPO in one of the EPO official languages on 22.06.2000 takes the place of the publication of the European patent application.
	[2001/41]
	Type:	B1 Patent specification
	No.:	EP1140139
	Date:	12.11.2003
	Language:	DE
	[2003/46]
	Type:	B9 Corrected patent specification
	No.:	EP1140139
	Date:	31.03.2004
	[2004/14]
	Type:	B2 New European patent specification
	No.:	EP1140139
	Date:	18.03.2009
	Language:	DE
	[2009/12]
Search report(s)	International search report - published on:	EP	19.10.2000
Classification	IPC:	A61K38/18, A61P9/10	[2001/41]
	CPC:	A61K38/1816 (EP,US); A61K38/22 (KR); A61P25/00 (EP); A61P9/00 (EP); A61P9/10 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/41]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	VERWENDUNG VON ERYTHROPOIETIN ODER ERYTHROPOIETIN-DERIVATEN ZUR BEHANDLUNG VON CEREBRALEN ISCHÄMIEN	[2001/41]
	English:	USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA	[2001/46]
	French:	UTILISATION DE L'ERYTHROPOIETINE OU DE DERIVES DE L'ERYTHROPOIETINE POUR TRAITER LES ISCHEMIES CEREBRALES	[2001/46]
	Former [2001/41]	METHOD FOR THE TREATMENT OF CEREBRAL ISCHAEMIA AND USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA
	Former [2001/41]	METHODE DE TRAITEMENT DES ISCHEMIES CEREBRALES ET UTILISATION DE L'ERYTHROPOIETINE OU DE DERIVES DE L'ERYTHROPOIETINE POUR TRAITER LES ISCHEMIES CEREBRALES
Entry into regional phase	04.07.2001	National basic fee paid
	04.07.2001	Designation fee(s) paid
	04.07.2001	Examination fee paid
Examination procedure	20.04.2000	Request for preliminary examination filed International Preliminary Examining Authority: EP
	04.07.2001	Examination requested [2001/41]
	31.08.2001	Amendment by applicant (claims and/or description)
	23.10.2001	Despatch of a communication from the examining division (Time limit: M06)
	26.04.2002	Reply to a communication from the examining division
	22.05.2003	Communication of intention to grant the patent
	02.09.2003	Fee for grant paid
	02.09.2003	Fee for publishing/printing paid
Opposition(s)	Opponent(s)	01 12.08.2004 20.08.2004 ADMISSIBLE H. Lundbeck A/S Ottilavej 9 2500Valby / DK Opponent's representative Engelhard, Elisabeth, et al, et al Hoffmann . Eitle ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR / DE
		02 12.08.2004 20.08.2004 ADMISSIBLE Fischer, Heinrich Maximilianstrasse 54 80538 München / DE Opponent's representative Ricker, Mathias, et al, et al Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB Zweibrückenstraße 5-7 80331 München / DE
		[N/P]
	Former [2007/32]
	Opponent(s)	01 12.08.2004 20.08.2004 ADMISSIBLE H. Lundbeck A/S Ottilavej 9 2500Valby / DK Opponent's representative Engelhard, Elisabeth, et al, et al Hoffmann . Eitle Arabellastrasse 4 81925 München / DE
		02 12.08.2004 20.08.2004 ADMISSIBLE Fischer, Heinrich Maximilianstrasse 54 80538 München / DE Opponent's representative Ricker, Mathias, et al, et al Wallinger Ricker Schlotter Foerstl Patent- und Rechtsanwälte Zweibrückenstrasse 2 80331 München / DE
	Former [2007/02]
	Opponent(s)	01 12.08.2004 20.08.2004 ADMISSIBLE H. Lundbeck A/S Ottilavej 9 2500Valby / DK Opponent's representative Engelhard, Elisabeth, et al, et al Hoffmann . Eitle Arabellastrasse 4 81925 München / DE
		02 12.08.2004 20.08.2004 ADMISSIBLE Fischer, Heinrich Maximilianstrasse 54 80538 München / DE Opponent's representative Ricker, Mathias, et al, et al Jones Day, Rechtsanwälte, Attorneys-at-Law, Patentanwälte, Prinzregentenstrasse 11 80538 München / DE
	Former [2004/43]
	Opponent(s)	01 12.08.2004 H. Lundbeck A/S Ottilavej 9 2500Valby / DK Opponent's representative Engelhard, Elisabeth, Dr., et al, et al Hoffmann . Eitle Arabellastrasse 4 81925 München / DE
		02 12.08.2004 Fischer, Heinrich Maximilianstrasse 54 80538 München / DE Opponent's representative Fischer, Heinrich, et al, et al Strehl Schübel-Hopf & Partner, Maximilianstrasse 54 80538 München / DE
	Former [2004/41]
	Opponent(s)	01 12.08.2004 ADMISSIBLE H. Lundbeck A/S Ottilavej 9 2500Valby / DK Opponent's representative Engelhard, Elisabeth, Dr., et al, et al Hoffmann . Eitle Arabellastrasse 4 81925 München / DE
		02 13.08.2004 Fischer, Heinrich Maximilianstrasse 54 80538 München / DE Opponent's representative Fischer, Heinrich, et al, et al Strehl Schübel-Hopf & Partner, Maximilianstrasse 54 80538 München / DE
	20.09.2004	Invitation to proprietor to file observations on the notice of opposition
	19.05.2005	Reply of patent proprietor to notice(s) of opposition
	07.12.2006	Date of oral proceedings
	28.12.2006	Despatch of minutes of oral proceedings
	24.07.2008	Despatch of interlocutory decision in opposition
	24.07.2008	Legal effect of interlocutory decision in opposition
	19.01.2009	Despatch of communication that the patent will be maintained as amended
	28.01.2009	Fee for printing new specification paid
Appeal following opposition	01.03.2007	Appeal received No. T0293/07
	07.05.2007	Statement of grounds filed
	24.07.2008	Result of appeal procedure: maintenance in amended form
	22.02.2007	Appeal received No. T0293/07
	15.02.2007	Appeal received No. T0293/07
	24.07.2008	Date of oral proceedings
	29.07.2008	Minutes of the oral proceedings despatched
Fees paid	Renewal fee
	21.12.2001	Renewal fee patent year 03
	23.12.2002	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]JPH05246885 ;
		[A]WO9714307 (ST ELIZABETHS MEDICAL CT [US]) [A] 1-24 * page 4, line 12 - page 5, line 22 * * claims 1-3,9-11 *;
		[A] - RUSCHER K ET AL, "Erythropoietin protects neurons from oxygen/glucose deprivation induced cell death.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, 28th Annual Meeting of the Society for Neuroscience, Part 1;Los Angeles, California, USA; November 7-12, 1998, (1998), vol. 24, no. 1-2, ISSN 0190-5295, page 298, XP000923282 [A] 1-24 * the whole document *
		[DA] - SAKANAKA M ET AL, "In vivo evidence that erythropoietin protects neurons from ischemic damage", PROC NATL ACAD SCI USA, (199804), vol. 95, pages 4635 - 4640, XP002142085 [DA] 1-24 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.95.8.4635
		[A] - BUNDESVERBAND DER PHARMAZEUTISCHEN INDUSTRIE E.V., Rote Liste 1998, AULENDORF/WURTT., EDITION CANTOR.; DE, (1998), XP002142086 [A] 1-24 * NeoRecormon-Fachinfo-Service 08045 *
		[A] - PATENT ABSTRACTS OF JAPAN, (19940106), vol. 018, no. 001, Database accession no. (C - 1148), & JP05246885 A 19930924 (CHUGAI PHARMACEUT CO LTD) [A] 1-24 * abstract *
		[AD] - DEL MASTRO L ET AL, "Strategies for the use of epoetin alfa in breast cancer patients", ONCOLOGIST, (1998), vol. 3, no. 5, pages 314 - 318, XP000923283 [AD] 1-24 * das ganze Document, insbesondere die Zusammenfassung und der Kommentar *
		[PX] - MARTI H H ET AL, "Protective role of erythropoietin in brain ischemia.", PHYSIOLOGICAL RESEARCH, Second Congress of the Federation of European Physiological Societies and Czech Physiological Society;Prague, Czech Republic; June 30-July 4, 1999, (1999), vol. 48, no. SUPPL. 1, ISSN 0862-8408, page S14, XP000923284 [PX] 1-24 * the whole document *
	Examination	- ALBAYRAK S. ET AL, "Effect of transient focal ischemia on blood-brain barrier permeability in the rat : correlation to cell inury", ACTA NEUROPATHOL, (1997), vol. 94, pages 158 - 163
		- MARTI H.H. ET AL, "Detection of erypoeitin in human liquor : Intrinsic erythropoietin production in the brain", KIDNEY INTERNATIONAL, (1997), vol. 51, pages 146 - 418
	Opposition	- S. A. MENZIES ET AL., "Extravasation of albumin in ischaemic brain oedema", ACTA NEUROCHIRURGICA, (1990), vol. SUPPL. 51, pages 220 - 222
		- R. SUZUKI ET AL., "The effect of 5-minute ischemia in mongolian gerbils: I. Blood-brain barrier, cerebral glucose flow, and local cerebral glucose utilization changes", ACTA NEUROPATHOL., (1983), vol. 60, pages 207 - 216
		- E. M. LOBERG ET AL., "Neuronal uptake of plasma proteins after transient cerebral ischemia/hypoxia", APMIS, (1993), vol. 101, pages 777 - 783

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 34p